Indication

Dermatitis herpetiformis

Dermatitis herpetiformis is a chronic, relapsing autoimmune blistering dermatosis that serves as the primary cutaneous manifestation of gluten-sensitive enteropathy (celiac disease). Read more about Dermatitis herpetiformis

347 drugs 166 manufacturers

Advertisement

Drugs that treat it

Common Dermatitis herpetiformis therapies.

Showing 37–45 of 347 drugs

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
CADISTA PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Dermatitis herpetiformis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Dermatitis herpetiformis.

Dermatitis herpetiformis is a chronic, relapsing autoimmune blistering dermatosis that serves as the primary cutaneous manifestation of gluten-sensitive enteropathy (celiac disease).

Primarily affecting adults and most frequently presenting in individuals of northern European ancestry, it targets the integumentary system while reflecting systemic immune dysregulation triggered by dietary gluten.

Clinically, it is characterized by intensely pruritic, grouped papulovesicular eruptions distributed symmetrically over extensor surfaces, including the elbows, knees, buttocks, and posterior scalp.

Pathophysiologically, the disorder is defined by circulating IgA antibodies against transglutaminases, leading to pathognomonic granular IgA deposits in the superficial dermal papillae that recruit neutrophils and form subepidermal microabscesses.

Personalize your experience

Follow Dermatitis herpetiformis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it